Key to Lung Cancer Chemo Resistance Found
Posted on: Wednesday, 11 October 2006, 12:01 CDT
U.S. scientists have discovered how a detox gene causes chemotherapy resistance in a common form of lung cancer.
Johns Hopkins University researchers say products made by a gene called NRF2 normally protect cells from environmental pollutants such as cigarette smoke by absorbing the materials and pumping them from the cell. Another gene called KEAP1 encodes products that halt the cleansing process. But lung cancer cells sabotage the expression of these same genes to block assault from chemotherapy drugs.
What we're seeing is that lung cancer cells recruit and distort NRF2 and KEAP1 expression to help tumor cells evade the toxic effects of chemotherapy, said Associate Professor Shyam Biswal, who led the cell culture study.
Biswal said blocking NRF2 activity could improve the effectiveness of standard chemotherapy drugs, particularly platinum-based compounds widely used for lung cancer.
The research appears in the Oct. 3 issue of the journal PLoS Medicine.
Source: United Press International
Related Articles
- Cancer cells need healthy genes to survive
- Lung Cancer Cells Activate Inflammation To Induce Metastasis
- PhytoMedical's Patented Anti-Cancer Compounds Kill Lung Cancer Cells, a Significant New Finding
- Green Tea Beneficial in Lung-Cancer Study
- Unique Structure of Geron's Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells
- Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test
- Gene Test May Help Lung Cancer Patients
- DNA Scans Reveal Possible Location of Lung Cancer Genes
- Vitamin E From Seeds Kills Cancer Cells
- Vitamine E From Seeds Kills Cancer Cells
 |
 |
User Comments (0)
RSS Feeds